153 related articles for article (PubMed ID: 34824355)
1. RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
Rofes P; Pineda M; Feliubadaló L; Menéndez M; de Cid R; Gómez C; Montes E; Capellá G; Brunet J; Del Valle J; Lázaro C
Sci Rep; 2021 Nov; 11(1):22948. PubMed ID: 34824355
[TBL] [Abstract][Full Text] [Related]
2. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
[TBL] [Abstract][Full Text] [Related]
3.
Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
[TBL] [Abstract][Full Text] [Related]
4. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
[TBL] [Abstract][Full Text] [Related]
5. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract][Full Text] [Related]
6. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
7. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
9. Summary of
Suszynska M; Kozlowski P
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32679805
[TBL] [Abstract][Full Text] [Related]
10. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
11. BARD1: an independent predictor of survival in non-small cell lung cancer.
Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
[TBL] [Abstract][Full Text] [Related]
12. Literature Review of
Alenezi WM; Fierheller CT; Recio N; Tonin PN
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32726901
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
[TBL] [Abstract][Full Text] [Related]
15. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
16. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
[TBL] [Abstract][Full Text] [Related]
17. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.
De Brakeleer S; De Grève J; Loris R; Janin N; Lissens W; Sermijn E; Teugels E
Hum Mutat; 2010 Mar; 31(3):E1175-85. PubMed ID: 20077502
[TBL] [Abstract][Full Text] [Related]
18. Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.
Pilyugin M; André PA; Ratajska M; Kuzniacka A; Limon J; Tournier BB; Colas J; Laurent G; Irminger-Finger I
Oncotarget; 2017 Feb; 8(6):9339-9353. PubMed ID: 28030839
[TBL] [Abstract][Full Text] [Related]
19. BARD1 expression predicts outcome in colon cancer.
Sporn JC; Hothorn T; Jung B
Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
[TBL] [Abstract][Full Text] [Related]
20. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.
Gorringe KL; Choong DY; Visvader JE; Lindeman GJ; Campbell IG
Breast Cancer Res Treat; 2008 Oct; 111(3):505-9. PubMed ID: 17972171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]